Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2010
At a glance
- Drugs Rosuvastatin (Primary) ; Celecoxib
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Pharmacodynamics
- 11 Apr 2010 Results reported in the Journal of the Amercian College of Cardiology.
- 11 Apr 2010 New trial record.